Antithrombin III progressive function: a biochemical analysis.

Abstract:

:Antithrombin III (AT III) was isolated by two procedures using polyethylene glycol-400 (PEG) precipitation as the first stage. The PEG supernatant (PEG-sup) was applied to a heparin-affinity chromatographic system and AT III-heparin cofactor (AT III-HCF) was isolated. The PEG precipitate (PEG-ppt) was separated by a Sephacryl S-200 column. Fractions were collected and those demonstrating maximum AT III antigen and progressive thrombin inhibition were pooled and reapplied to the washed Sephacryl S-200 column. Fractions were again collected and assayed via specific antisera for AT III, alpha 1-antitrypsin (alpha 1 AG), alpha 2-macroglobulin (alpha 2 M), and alpha 1-acid glycoprotein (alpha 1 AT). AT III antigen (AT III AGN) and progressive function were confined primarily to one peak containing virtually no alpha 2 M, a low level of alpha 1 AT, and moderate quantities of alpha 1 AG. The PEG-sup, PEG-ppt, AT III-HCF, and the fraction obtained after two passes across Sephacryl S-200 (S#2) were similar in that they showed reactivity with specific AT III antisera and demonstrated heparin cofactor activity. They differed, however, in that the PEG-sup and AT III-HCF demonstrated considerably reduced progressive antithrombin function assessed over 30 min. This function was present in the PEG-ppt and S#2 fractions and this progressive activity was potentiated by EDTA. AT III two-dimensional immunoelectrophoresis (2-DIE) in the presence of heparin of both the Sephacryl and heparin-affinity purified components were very different, with the Sephacryl-purified AT III AGN showing both a fast peak and a very prominent slow-moving hump. The AT III heparin affinity fraction showed primarily a fast component. Dilution of the S#2 and PEG-ppt fractions resulted in considerable loss of the progressive activity and also the slow-moving component on 2-DIE. On the basis of these observations, it is postulated that AT III purified by PEG precipitation is in an aggregated form and that aggregate formation and dissolution is associated with AT III progressive activity.

journal_name

Am J Hematol

authors

Gomperts ED,Izadi P

doi

10.1002/ajh.2830150104

subject

Has Abstract

pub_date

1983-08-01 00:00:00

pages

23-33

issue

1

eissn

0361-8609

issn

1096-8652

journal_volume

15

pub_type

杂志文章
  • Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets.

    abstract::Botrocetin, a protein isolated from the venom of the snake Bothrops jararaca, induces platelet aggregation/agglutination by von Willebrand factor (vWF) binding to the membrane glycoprotein (GP) Ib, an action resembling that of ristocetin. However, some differences in the interaction between vWF and platelet GPIb induc...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830330409

    authors: Nishio K,Fujimura Y,Niinomi K,Takahashi Y,Yoshioka A,Fukui H,Usami Y,Titani K,Ruggeri ZM,Zimmerman TS

    更新日期:1990-04-01 00:00:00

  • The prognostic value of hematogones in patients with acute myeloid leukemia.

    abstract::In acute myeloid leukemia (AML), new prognostic tools are needed to assess the risk of relapse. Hematogones (HGs) are normal B-lymphocyte precursors that increase in hematological diseases and may influence remission duration in AML. HG detection was prospectively investigated in 262 AML patients to determine its prog...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24350

    authors: Chantepie SP,Parienti JJ,Salaun V,Benabed K,Cheze S,Gac AC,Johnson-Ansah H,Macro M,Damaj G,Vilque JP,Reman O

    更新日期:2016-06-01 00:00:00

  • Gentle yet effective treatment for elderly patients with refractory or relapsing multiple myeloma.

    abstract::Fourteen patients, aged 65-85 years, with refractory (11) or relapsing (3) multiple myeloma were treated with a "protracted-sequential" protocol comprising vincristine 1-2 mg or vindesine 3 mg/M(2) (max. 5 mg) IVI over 4 hr on D1, prednisolone 40-50 mg PO D1-14, and melphalan 2-4 mg PO or cyclophosphamide 50-100 mg PO...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1002/1096-8652(200009)65:1<81::aid-ajh15>3.0.co

    authors: Manoharan A

    更新日期:2000-09-01 00:00:00

  • Increased Heinz body formation and impaired erythrocyte pentose phosphate shunt function during pregnancy.

    abstract::The erythrocytes of 90 pregnant women were evaluated for the presence of in vivo or in vitro oxidant damage. The reduced glutathione (P less than 0.005) and the membrane reduced sulfhydryl (P less than 0.001) concentrations were decreased in fresh erythrocytes. Following incubation with acetylphenylhydrazine, Heinz bo...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830180204

    authors: Lachant NA,Gottlieb AJ,DiFino SM,Landaw SA,Tanaka KR

    更新日期:1985-02-01 00:00:00

  • Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes.

    abstract::Iron studies were compared in 434 patients from 80 hemochromatosis families classified as putative homozygotes, heterozygotes, and normal by HLA typing. There were 28 of 255 (11%) heterozygotes with an elevated serum ferritin and 22 of 255 (8.6%) with an elevated transferrin saturation. Serum ferritin (140 +/- 10.2 mi...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830450210

    authors: Adams PC

    更新日期:1994-02-01 00:00:00

  • Chromosome changes in a patient achieving complete remission in the acute phase of chronic myelogenous leukemia.

    abstract::A patient with chronic myelogenous leukemia (CML) had a Philadelphia chromosome (Ph') [t(9q+;22q-)] in all cells and trisomy C in 13% of cells (later determined to be trisomy 8) at the time of diagnosis. After 21 months of intermittent treatment with busulfan, the acute phase developed with the appearance of an additi...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830060208

    authors: Stern R,Sorenson J,Wurster-Hill DH,Cornwell GG 3rd,McIntyre OR

    更新日期:1979-01-01 00:00:00

  • Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease.

    abstract::Limited data are available regarding optimal treatment with desmopressin (DDAVP) or intermediate-purity FVIII concentrates rich in VWF (CFCs) in patients with von Willebrand disease (VWD) who undergo planned surgery. We undertook a retrospective review over 10 years (1988-1997) and identified 27 patients treated with ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1002/ajh.1058

    authors: Nitu-Whalley IC,Griffioen A,Harrington C,Lee CA

    更新日期:2001-04-01 00:00:00

  • Treatment of acquired severe aplastic anemia with antilymphocyte globulin, cyclosporin A, methyprednisolone, and granulocyte colony-stimulating factor.

    abstract::Fifty-six adult patients with newly diagnosed acquired severe aplastic anemia (SAA) received horse antilymphocyte globulin (ALG), cyclosporin A (CyA), methylprednisolone (Mpred), granulocyte colony-stimulating factor (G-CSF) as first-line therapy. The median age was 34 (range, 17-72) and median neutrophil count 0.280 ...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1002/ajh.20954

    authors: Dinçol G,Aktan M,Diz-Küçükkaya R,Yavuz S,Nalçaci M,Oztürk S,Palanduz S,Doğan O,Ağan M

    更新日期:2007-09-01 00:00:00

  • Transformation of bilineal hybrid acute leukemia to acute lymphoid leukemia: a case report with serial analyses of cytogenetics and gene rearrangement.

    abstract::A 17-year-old male with bilineal hybrid acute leukemia is described. Two-color flow cytometric analysis of blast surface phenotype revealed that there were two groups of blasts which showed either CD 10+ CD 19+ CD 13- CD 33- or CD 10- CD 19- CD 13+ CD 33+, but not both. He developed a complete remission by treatment w...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830350211

    authors: Jinnai I,Kusumoto S,Shiomi Z,Bessho M,Saitoh M,Hirashima K,Minamihisamatsu M,Kamiyama T,Takase K

    更新日期:1990-10-01 00:00:00

  • Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.

    abstract::Acquired α-thalassemia myelodysplastic syndrome (MDS) (ATMDS) is an acquired syndrome characterized by a somatic point mutation or splicing defect in the ATRX gene in patients with myeloid disorders, primarily MDS. In a large MDS patient series, the incidence of ATMDS was below 0.5%. But no large series has yet assess...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.24073

    authors: Herbaux C,Duployez N,Badens C,Poret N,Gardin C,Decamp M,Eclache V,Daliphard S,Murati A,Cony-Makhoul P,Cheze S,Beve B,Lacoste C,Prebet T,Hunault-Berger M,Maloisel F,Renneville A,Figeac M,Stamatoullas-Bastard A,Bastar

    更新日期:2015-08-01 00:00:00

  • Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.

    abstract::Children with sickle cell anemia (SCA) and a primary overt stroke are at high risk of recurrent (secondary) stroke. Chronic transfusion therapy dramatically reduces but does not eliminate this high risk, and inevitably results in transfusion-related hemosiderosis. We previously reported the use of hydroxyurea/phleboto...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.21986

    authors: Greenway A,Ware RE,Thornburg CD

    更新日期:2011-04-01 00:00:00

  • Atypical haplotypes linked to the beta S gene in Africa are likely to be the product of recombination.

    abstract::We report here the haplotypes of 10 MstII-defined SS patients and a S/beta o thalassemia from the Central African Republic, exhibiting 7 different atypical haplotypes that are different from the typical Bantu haplotype that characterize over 93% of the beta s bearing chromosomes in that region of Africa. Of the seven ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830290117

    authors: Srinivas R,Dunda O,Krishnamoorthy R,Fabry ME,Georges A,Labie D,Nagel RL

    更新日期:1988-09-01 00:00:00

  • A serum ferritin assay for prevalence studies of iron deficiency.

    abstract::A specialized serum ferritin assay has been developed for the detection of iron deficiency in epidemiologic studies. An enzyme immunoassay (EIA) was employed to eliminate the need for radioisotopes. The problem of low sensitivity inherent with the EIA for serum ferritin was eliminated by the use of monoclonal immunolo...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830230209

    authors: Flowers CA,Kuizon M,Beard JL,Skikne BS,Covell AM,Cook JD

    更新日期:1986-10-01 00:00:00

  • Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.

    abstract::Celecoxib, a specific cyclooxygenase-2 (Cox-2) inhibitor, has been shown to possess antitumor activity in a variety of cancer cells. However, the antitumor activity of celecoxib in hematopoietic tumors, especially in chronic myeloid leukemia (CML), has not been well established. This study was designed to investigate ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20542

    authors: Zhang GS,Liu DS,Dai CW,Li RJ

    更新日期:2006-04-01 00:00:00

  • Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group.

    abstract::Transformation to secondary myelofibrosis (MF) occurs as part of the natural history of polycythemia vera (PPV-MF) and essential thrombocythemia (PET-MF). Although primary (PMF) and secondary MF are considered similar diseases and managed similarly, there are few studies specifically focused on the latter. The aim of ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ajh.24377

    authors: Rotunno G,Pacilli A,Artusi V,Rumi E,Maffioli M,Delaini F,Brogi G,Fanelli T,Pancrazzi A,Pietra D,Bernardis I,Belotti C,Pieri L,Sant'Antonio E,Salmoiraghi S,Cilloni D,Rambaldi A,Passamonti F,Barbui T,Manfredini R,Ca

    更新日期:2016-07-01 00:00:00

  • Release of granulocyte-macrophage colony-inhibiting activity by normal human postthymic precursor cells.

    abstract::Seven normal human peripheral blood cell fractions (buffy coat, mononuclear cells, non-T, T, Fc-IgM receptor-depleted T-lymphocyte, Fc-IgG receptor-depleted T-lymphocyte, and autologous rosette-forming T-cell-depleted T-lymphocyte subpopulations) treated with phytohemagglutinin (PHA) were examined for the production o...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830200306

    authors: López-Karpovitch X,Padrós-Semorile MR,Rojas R,Martínez-Sánchez L

    更新日期:1985-11-01 00:00:00

  • Visceral leishmaniasis masquerading as myelodysplasia.

    abstract::We report a case of a 61-year-old man with head and neck cancer who presented with pancytopenia two months after the completion of his chemotherapy and was diagnosed with myelodysplasia on the basis of two bone marrow examinations, before the correct diagnosis of visceral leishmaniasis was established with splenectomy...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.10408

    authors: Kopterides P,Halikias S,Tsavaris N

    更新日期:2003-11-01 00:00:00

  • Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical

    abstract::We studied the prognostic value of parameters of angiogenesis on bone marrow biopsies in newly diagnosed multiple myeloma (MM) patients. Angiogenesis parameters studied were the microvessel count done manually on light microscopy (MVD-A), microvessel count done by using computerized image analyzer (MVD-B), and total v...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20639

    authors: Bhatti SS,Kumar L,Dinda AK,Dawar R

    更新日期:2006-09-01 00:00:00

  • Thrombosis following desmopressin for uremic bleeding.

    abstract::An elderly patient with evidence of atherosclerosis and uremic bleeding diathesis developed two foci of cerebral thrombosis immediately after an infusion of desmopressin (DDAVP). Because large molecular weight multimers of von Willebrand factor (vWF) have been demonstrated to cause platelet aggregation under condition...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830280115

    authors: Byrnes JJ,Larcada A,Moake JL

    更新日期:1988-05-01 00:00:00

  • Induction of carbonic anhydrase I isozyme precedes the globin synthesis during erythropoiesis in K562 cells.

    abstract::Induction of carbonic anhydrase isozyme I (CA-I) by erythropoietin or hemin was investigated using erythroleukemia (K562) cells. Immunological estimation and purification of carbonic anhydrases showed that untreated K562 cells contained only carbonic anhydrase isozyme II(CA-II), while incubation of the cells with 2 un...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830380309

    authors: Kondo T,Sakai M,Isobe H,Taniguchi N,Nishi S,Kawakami Y

    更新日期:1991-11-01 00:00:00

  • Peripheral blood remission of hairy cell leukemia after transfusion hepatitis.

    abstract::Hairy cell leukemia is a chronic lymphoproliferative disorder characterized clinically by splenomegaly and cytopenias. Spontaneous remissions are rare and splenectomy is often performed when the blood counts worsen and cause symptoms. Three of our patients with hairy cell leukemia developed recurrent pancytopenia and ...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830250307

    authors: Keefer MJ,Weber MJ,Bottomley SS,Solanki DL,Hosty TA

    更新日期:1987-07-01 00:00:00

  • Long-term results of single-agent thalidomide as initial therapy for asymptomatic (smoldering or indolent) myeloma.

    abstract::We report the long-term follow-up results of a phase II trial of thalidomide for early-stage multiple myeloma (MM). Patients were eligible if they had smoldering multiple myeloma (SMM) or indolent MM without the need for immediate therapy. Thalidomide was initiated at a dose of 200 mg/day and adjusted as tolerated. Di...

    journal_title:American journal of hematology

    pub_type: 临床试验,杂志文章

    doi:10.1002/ajh.21821

    authors: Detweiler-Short K,Hayman S,Gertz MA,Lacy MQ,Dispenzieri A,Kumar S,Zeldenrust SR,Russell SJ,Lust JA,Kyle RA,Greipp PR,Witzig TE,Vincent Rajkumar S

    更新日期:2010-10-01 00:00:00

  • Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.

    abstract::The effect of several iron chelators on iron uptake and release by mouse peritoneal macrophages has been investigated. The 1,2-dimethyl (L1) and 1-ethyl-2-methyl (L1NEt) derivatives of 3-hydroxypyrid-4-one markedly enhanced iron mobilisation from macrophages pulsed with 59Fe-transferrin-antitransferrin immune complexe...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830340106

    authors: Brock JH,Licéaga J,Arthur HM,Kontoghiorghes GJ

    更新日期:1990-05-01 00:00:00

  • Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome.

    abstract::We report a case of a patient who developed a fatal adult respiratory distress syndrome (ARDS) during treatment with rh granulocyte-macrophage colony stimulating factor (rhGM-CSF) (250 mcg/m2/day s.c.) and low-dose cytosine-arabinoside (Ara-C) (20 mg/m2/day s.c.). Several mechanisms which might explain the lung tissue...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830360413

    authors: Verhoef G,Boogaerts M

    更新日期:1991-04-01 00:00:00

  • Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?

    abstract::Corticosteroids are essential and one of the mainstays in the treatment of acute lymphoblastic leukemia (ALL). In vitro assays show that dexamethasone(DXM) is five to six times more cytotoxic to leukemic lymphoblasts than prednisolone (PDN) [1], and the use of DXM as an alternative drug for PDN is an important issue i...

    journal_title:American journal of hematology

    pub_type: 信件,随机对照试验

    doi:10.1002/ajh.21827

    authors: Zheng C,Liu X,Wu J,Cai X,Zhu W,Sun Z

    更新日期:2010-10-01 00:00:00

  • Effects of continuous high dose rhGM-CSF infusion on human monocyte activity.

    abstract::In this study we describe the time-dependent effects of a high dose (750 micrograms/ml/24 hr) continuous infusion of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) on monocyte number, cytokine release, and superoxide anion production. Blood was taken from patients prior to rhGM-CSF infus...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830430410

    authors: Perkins RC,Vadhan-Raj S,Scheule RK,Hamilton R,Holian A

    更新日期:1993-08-01 00:00:00

  • Genomic Characteristics and Prognostic Significance of Co-mutated ASXL1/SRSF2 Acute Myeloid Leukemia.

    abstract::ASXL1 and SRSF2 mutations in AML are frequently found in patients with preexisting myeloid malignancies and are individually associated with poor outcomes. In this multi-institutional retrospective analysis, we assessed the genetic features and clinical outcomes of 43 patients with ASXL1mut SRSF2mut AML and compared o...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.26110

    authors: Richardson DR,Swoboda DM,Moore DT,Johnson SM,Chan O,Galeotti J,Esparza S,Hussaini MO,Van Deventer H,Foster MC,Coombs CC,Montgomery ND,Sallman DA,Zeidner JF

    更新日期:2021-01-27 00:00:00

  • Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.

    abstract::Although infectious complications represent a relevant cause of morbidity and mortality in patients with myelofibrosis (MF), little is known about their incidence, outcome and risk factors. We retrospectively evaluated a cohort of 507 MF patients, diagnosed between 1980 and 2014 in five Italian hematology centers, to ...

    journal_title:American journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1002/ajh.24572

    authors: Polverelli N,Breccia M,Benevolo G,Martino B,Tieghi A,Latagliata R,Sabattini E,Riminucci M,Godio L,Catani L,Nicolosi M,Perricone M,Sollazzo D,Colafigli G,Campana A,Merli F,Vitolo U,Alimena G,Martinelli G,Lewis RE,V

    更新日期:2017-01-01 00:00:00

  • Late relapses in Hodgkin disease.

    abstract::Among a cohort of 142 patients with Hodgkin disease (HD), pathologic stages (PS) IA through IVB, 84 remained in complete remission (CR) at least 3 years after the completion of initial protocol therapy. Eight of these patients subsequently developed a recurrence of HD and were defined as having a late relapse. The dis...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.2830100106

    authors: Kanofsky JR,Golomb HM,Vardiman JE,Sweet DL,Ultmann JE

    更新日期:1981-01-01 00:00:00

  • Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.

    abstract::Several parameters may predict disease severity and overall survival in chronic lymphocytic leukemia (CLL). The purpose of our study of 190 CLL patients was to compare immunoglobulin heavy chain variable region (IgV(H)) mutation status, cytogenetic abnormalities, and leukemia cell CD38 and Zap-70 to older, traditional...

    journal_title:American journal of hematology

    pub_type: 杂志文章

    doi:10.1002/ajh.20987

    authors: Weinberg JB,Volkheimer AD,Chen Y,Beasley BE,Jiang N,Lanasa MC,Friedman D,Vaccaro G,Rehder CW,Decastro CM,Rizzieri DA,Diehl LF,Gockerman JP,Moore JO,Goodman BK,Levesque MC

    更新日期:2007-12-01 00:00:00